Vanderbilt Genetics Institute
-
September 3, 2020
New clue to Alzheimer’s disease
Combining studies of genetically diverse mouse populations and human data led to the identification of a gene associated with cognitive decline and brain changes in Alzheimer’s disease. -
September 3, 2020
Bick receives Burroughs Wellcome Fund Career Award for Medical Scientists
Alexander Bick, MD, PhD, assistant professor of Medicine in the Division of Genetic Medicine at Vanderbilt University Medical Center, is a recipient of the 2020 Burroughs Wellcome Fund (BWF) Career Award for Medical Scientists. -
April 30, 2020
EHRs, biobanks and Mendelian diseases
Electronic health records and biobanks can be effectively combined to detect and study Mendelian diseases such as cystic fibrosis. -
April 23, 2020
VUMC joins global effort to explore COVID-19 genetics
Vanderbilt University Medical Center investigators have joined an international genetics effort to make advances as quickly as possible on understanding and treating COVID-19. -
January 13, 2020
Vanderbilt-led team discovers new genetic disease and defines underlying mechanism
An international research team has discovered a new genetic syndrome caused by mutation of a single gene and named it CATIFA, an acronym for its core symptoms. -
November 7, 2019
Study explores genetic risk profiling of insomnia in autism
Vanderbilt researchers are studying how genes affect sleep and circadian disturbances in autism spectrum disorder (ASD) with a goal of creating a genetic risk profile of insomnia in ASD. -
September 19, 2019
Gamazon receives NIH Genomic Innovator Award
VUMC's Eric Gamazon is one of only six investigators to receive an inaugural Genomic Innovator Award from the National Human Genome Research Institute, part of the NIH.